Endocrine alterations and imuno-modulation on pregnancy;Alterações endócrinas e imuno-modulação na gravidez

Arquivos de Medicina

Volumn 21, Issue 5-6, 2007, Pages 175-182

  Neves, Celestino ^a   Medina, José Luís ^a   Delgado, José Luís ^a  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Autoimmunity; Endocrine system; Post partum period; Pregnancy

Indexed keywords

CYTOKINE;

ADENOHYPOPHYSIS; ADRENAL GLAND; EMBRYO DEVELOPMENT; ENDOCRINE DISEASE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MACROPHAGE; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROHYPOPHYSIS; PHYSICAL DEVELOPMENT; PREGNANCY; REVIEW; T LYMPHOCYTE; TH2 CELL; THYROID GLAND;

EID: 56049094152     PISSN: 08713413     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Mulder JE. Thyroid disease in women. Women's health issue, part I. Med Clin N Am 1998;82:103-1123.
2. Scheithauer BW, Sano T, Kovacs KT, Young WF Jr, Ryan N, Randall RV. The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 1990;65:461-74.
3. Tyson JE, Hwang P, Guyda H, Friesen HG. Studies of prolactin secretion in human pregnancy. Am J Obstet Gynecol 1972;113:14-20.
4. Ben-Jonathan N, Mershon JL, Allen IDL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996;17:639-69.
5. Evain-Brion D. Maternal endocrine adaptations to placental hormones in humans. Acta Paediatr Suppl 1999;88:12.
6. Emmi AM, Skurnick J, Goldsmith LT, et al. Ovarian control of pituitary hormone secretion in early human pregnancy. J Clin Endocrinol Metab 1991;72:1359-63.
7. Handwerger S, Brar A. Placental lactogen, placental growth hormone, and decidual prolactin. Semin Reprod Endocrinol 1992;10:106.
8. Alsat E, Guibourdenche J, Luton D, Frankenne F, Evain-Brion D. Human placental growth hormone. Am J Obstet Gynecol 1997;177:1526-34.
9. Yamashita S, Melmed S. Insulin like growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells. J Clin Invest 1987;79:449-52.
10. Tulchinsky D, Hobel CJ, Yeager E, Marshall JR. Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am J Obstet Gynecol 1972;112:1095-100.
11. Levitz M, Young BK. Estrogens in pregnancy. Vitam Horm 1977;35:109-47.
12. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997;18:404-33.
13. Genazzani AR, Fraioli F, Hurlimann J, Fioretti P, Felber JP. Immunoreactive ACTH and cortisol plasma levels during pregnancy. Detection and partial purification of corticotrophin-like placental hormone: the human chorionic corticotrophin (HCC). Clin Endocrinol 1975 4:1.
14. Okamoto E, Takagi T, Makino T, et al. Immunoreactive corticotropin-releasing hormone, adrenocorticotropin and cortisol in human plasma during pregnancy and delivery and postpartum. Horm Metab Res 1989;21:566-72.
15. Elster AD, Sanders TG, Vines FS, Chen MY. Size and shape of the pituitary gland during pregnancy and post partum: measurement with MR imaging. Radiology 1991; 181:531-5.
16. Davison JM, Shiells EA, Philips PR, Lindheimer MD. Serial evaluation of vasopressin release and thirst in human pregnancy. Role of human chorionic gonadotrophin in the osmoregulatory changes of gestation. J Clin Invest 1988; 81:798-806.
17. Stock S, Bremme K, Uvnas-Moberg K. Plasma levels of oxytocin during the menstrual cycle, pregnancy and following treatment with HMG. Hum Reprod 1991;6:1056-62.
18. Zeeman GG, Khan-Dawood FS, Dawood MY. Oxytocin and its receptor in pregnancy and parturition: current concepts and clinical implications. Obstet Gynecol 1997;89:873-83.
19. Davis OK, Hawkins DS, Rubin LP, Posillico JT, Brown EM, Schiff I. Serum parathyroid hormone (PTH) in pregnant women determined by an immunoradiometric assay for intact PTH. J Clin Endocrinol Metab 1988;67:850-2.
20. Bertelloni S, Baroncelli GI, Pelletti A, Battini R, Saggese G. Parathyroid hormone related protein in healthy pregnant women. Calcif Tissue Int 1994;54:195-7.
21. Moseley JM, Gillespie MT. Parathyroid hormone related protein? Crit Rev Clin Lab Sci 1995; 32:299-343.
22. Gertner JM, Coustan DR, Kliger AS, Mallette LE, Ravin N, Broadus AE. Pregnancy as state of physiologic absorptive hypercalciuria. Am J Med 1986;81:451-6.
23. Zerwekh JE, Breslau NA. Human placental production of 1 alpha, 25-dihydroxyvitamin D3: biochemical characterization and production in normal subjects and patients with pseudohypoparathyroidism. J Clin Endocrinol Metab 1986;62:192-6.
24. Carr BR, Parker CR Jr, Madden JD, MacDonald PC, Porter JC. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy. Am J Obstet Gynecol 1981;139:416-22.
25. Carr BR, Gant NF. The endocrinology of pregnancy-induced hypertension. Clin Perinatol 1983;10:737-61.
26. Casey ML, MacDonald PC. Extraadrenal formation of a mineralocorticosteroid: deoxycorticosterone and deoxycorticosterone sulphate biosynthesis and metabolism. Endocr Rev 1982;3:396-403.
27. Milewich L, Gomez-Sanchez C, Madden JD, et al. Dehydroisoandrosterone sulfate in peripheral blood of premenopausal, pregnant and postmenopausal women and men. J Steroid Biochem 1978;9:1159-64.
28. Tunbridge RD, Donnai P. Plasma noradrenaline in normal pregnancy and in hypertension of late pregnancy. Br J Obstet Gynaecol 1981;88:105-8.
29. Kincade PW, Medina KL, Smithson G, Scott DC. Pregnancy: a clue to normal regulation of B lymphopoiesis. Immunol Today 1994;15:539-44.
30. Smyth PA, Wijeyaretne CN, Kaluarachi WN, et al. Sequential studies on thyroid antibodies during pregnancy. Thyroid 2005;15:474-7.
31. Luppi P, Haluszczak C, Betters D, Richard CA, Trucco M, DeLoia JA. Monocytes are progressively activated in the circulation of pregnant women. J. Leukoc Biol 2002 72:874-84.
32. Thellin O, Coumans B, Zorzi W, Igout A, Heinen E. Tolerance to the foeto-placental 'graft:' ten ways to support a child for nine months. Curr Opin Immunol 2000;12:731-7.
33. Pazmany L, Mandelboim O, Vales-Gomez M, Davis DM, Reyburn HT, Strominger JL. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996;274:792-5.
34. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the roleof HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997;94:11520-5.
35. Carosella ED, Rouas-Freiss N, Paul P, Dausset J. HLA-G: A tolerance molecule from the major histocompatibility complex. Immunol Today 1999;20:60-62.
36. Horuzsko A, Lenfant F, Munn DH, Mellor AL. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 2001;13:385-94.
37. Jiang SP, Vacchio MS. Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft". J Immunol 1998; 160:3086-90.
38. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2001;2:64-8.
39. Bennett WA, Lagoo-Deenadayalan S, Whitworth NS, Stopple JA, Barber WH, Hale E, Brackin MN, Cowan BD. Expression and production of interleukin-10 by human trophoblast: relationship to pregnancy immunotolerance. Early Pregnancy Sep 1997;3:190-8.
40. Loke YW, King A, Gardner L, Carter NP. Evidence for the expression of granulocyte-macrophage colony-stimulating factor receptors by human first trimester extravillous trophoblast and its response to this cytokine. J Reprod Immunol Jun 1992;22:33-45.
41. Ando T, Imaizumi M, Graves PN, Unger P, Davies TF. Intrathyroidal fetal microchimerism in Graves' disease. J Clin Endocrinol Metab 2002;87:3315-20.
42. Watanabe M, Iwatani Y, Hidaka Y, Mitsuda N, Amino N. Changes in soluble CD4 CD8 proteins in healthy pregnant and postpartum women. Am J Reprod Immunol 1996; 36:220-7.
43. Weetman AP. The immunology of pregnancy. Thyroid 1999;9:643-6.
44. Matthiesen L, Berg G, Emerudh J, Hakansson L. Lymphocyte subsets and mitogen stimulation of blood lymphocytes in normal pregnancy. Am J Reprod Immunol 1996; 35:70-9.
45. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol. 1996;106:127-33.
46. Reinhard G, Noll A, Schlebush H, Mailman P, Ruecker AV. Shifts in the Th1/Th2 balance during human pregnancy correlate with apoptotic changes. Biochem Biophys Res Commun 1998;245:933-8.
47. Watanabe M, Iwatani Y, Kaneda T, Hidaka Y, Mitsuda N, Morim Y, Amino N. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol 1997;37:368-77.
48. Tsuda H, Sakai M, Michimata T, Tanebe K, Hayakawa S, Saito S. Characterization of NKT cells in human peripheral blood and decidual lymphocytes. Am J Reprod Immunol 2001;45:295-302.
49. Kawano T, Cui J, Koezuka Y, et al. Natural killer-like non-specific tumor cell lysis mediated by specific ligand-activated V14 NKT cells. Proc Natl Acad Sci USA 1998;95:5690-3.
50. Kakimi K, Guidotti, LG, Koezuka Y, Chisari FV. Natural Killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000;192:921-30.
51. Seino KI, Fukao K, Muramoto K, et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sc. USA 2001;98:2577-81.
52. Sonoda, KH, Taniguchi M, Stein-Streilein J. Long-Term Survival of Corneal Allografts Is Dependent on Intact CD1d-Reactive NKT Cells. J Immunol 2002;168:2028-34.
53. Dosiou C, Giudice LC. Natural Killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev 2005;26:44-62.
54. Boyson JE, Rybalov B, Koopman LA, et al. CD1d and invariant NKT cells at the human maternal-fetal interface. Proc. Natl Acad Sci 2002;99:13741-6.
55. Gao Y, Herndon JM, Zhang H, Griffith TS, Ferguson TA. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J Exp Med 1998;188:887-96.
56. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite. I Immunosuppressive effects of apoptotic cells. Nature 1997;390:350-1.
57. Rook AH, Kehrl JH, Wakefield LM, et al. Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 1986;136:3916-20.
58. Lee GL, Ellingsworth LR, Gillis S, Wall R, Kincade PW. β Transforming growth factors are potential regulators of B lymphopoiesis. J Exp Med 1987;166:1290-9.
59. Gerstein HC. How common is postpartum thyroiditis? A methodologic overview of the literature. Arch Intern Med 1990; 150:1397-1400.
60. Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with autoantibodies to interleukin 4. J Exp Med 1998; 188: 1929-39.
61. Hahm KB, Im YH, Lee C, Parks WT, Bang YJ, Green JE, Kim SJ. Loss of TGF-β signalling contributes to autoimmune pancreatitis. J Clin Invest 2000;105:1057-65.
62. Chernajovsky Y, Adams G, Triantaphyllopoulos K, Ledda MF, Podhajcer OL. Pathogenic lymphoid cells engineered to expressTGFβ1 ameliorate disease in a collagen-induced arthritis model. Gene Ther 1997;4:553-9.
63. Guimaraes VC, Quintans J, Fisfalen ME, et al. Immunosuppression of thyroiditis. Endocrinol 1996;137:2199-207.
64. Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-β-1 (TGF-β1) in autoimmune diseases. J Autoimm 2000;14:23-42.
65. Piccirillo CA, Chang Y, Prud'homme GJ. TGF-β1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. J Immunol 1998;161:3950-6.
66. Grande JP. Role of transforming growth factor-β in tissue injury and repair. Proc Soc Exp Biol Med 1997;214:27-40.
67. Clark DA, Falbo M, Rowley RB, Banwatt D, Stedronska-Clark J. Active suppression of host-vs-graft reaction in pregnant mice. IX. Soluble suppressor activity obtained from allopregriant mouse decidua that blocks the cytolytic effector response to IL-2 is related to transforming growth factor β. J Immunol 1988;141:3833-40.
68. Bridoux F, Badou A, Saoudi A, Bernard I, Druet E, Pasquier R, Druet P, Pelletier L, et al. Transforming growth factor β (TGF-β)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4+ T cell lines. J Exp Med 1997;185:1769-75.
69. Elenkov IJ, Wilder RL, Bakalov VK, et al. IL-12, TNF-γ, and hormonal changes during late pregnancy and early post-partum: implications for autoimmune disease activity during these times. J Clin Endcrinol Metab 2001; 86:4933-8.
70. Goland RS, Conwell IM, Warren WB, Wardlaw SL. Placental corticotropin-releasing hormone and pituitary-adrenal function during pregnancy. Neuroendocrinology 1992;56: 742-9.
71. Lindsay JR, Nieman LK. The hypothalamic-pituitary-adrenal axis in pregnancy: Challenges in disease detection and treatment. Endocr Rev 2005;26:775-99.
72. Piccinni MP, Giudizi MG, Biagiotti R, et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995;155:128-33.
73. Brosens, Gellersen B. Death or survival - progesterone-dependent cell fate decisions in the human endometrial stroma. J Mol Endocrinol 2006;36:389-98.
74. Szekeres-Bartho J, Kilar F, Falkay G, Csernus V, Torok A, Pacsa AS. The mechanism of the inhibitory effectof progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Immunol Microbiol 1985;9:15-8.
75. Faust Z, Laskarin G, Rukavina D, Szekeres-Bartho J. Progesterone-induced blocking factor inhibits degranulation of natural killer cells. Am J Reprod Immunol 1999; 42:71-5.
76. Szekeres-Bartho J, Autran B, Debre P, Andreu G, Denver L, Chaouat G. Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol 1989;122:281-94.
77. Szekeres-Bartho J, Wegmann TG. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 1996;31:81-95.
78. Dealtry GB, O'Farrell MK, Fernandez N. The Th2 cytokine environment of the placenta. Int Arch Allergy. Immunol 2000;123:107-19.
79. Laskarin G, Strbo N, Sotosek V, Rukavina D, Faust Z, Szekeres-Bartho J, Podack ER. Progesterone directly and indirectly affects perforin expression in cytolytic cells. Am J Reprod Immunol 1999;42:312-20.
80. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000;47:87-103.
81. Rochester DB, Davies TF. Increased riskof Graves' disease after pregnancy. Thyroid 2005;15:1287-90.
82. Nicholson WK. Prevalence of postpartum thyroid dysfunction: a quantitative review. Thyroid 2006;16:573-82.
83. Schindler AE. Endocrinology of pregnancy: consequences for the diagnosis and treatment of pregnancy disorders. J Steroid Biochem Mol Biol 2005;97:386-8.
84. Redmond GP. Thyroid dysfunction and women's reproductive health. Thyroid 2004;14:5-15.
85. Premawardhana LDKE, Parkes AB, John R, Harris B, Lazarus JH. Thyroid peroxidase antibodies in early pregnancy: utility for prediction of postpartum thyroid dysfunction and implications for screening.Thyroid 2004;14:610-5.
86. Wang H, Sudhansu K. Dey SD, Maccarrone M. Jekyll and Hyde: two faces of cannabinoid signaling in male and female fertility. Endocr Rev 2006;27:427-48.
87. Dosiou C, Giudice LC. Natural Killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev 2005;26:44-62.